Natural History of Myocardial αvβ3 Integrin Expression After Acute Myocardial Infarction : Correlation with Changes in Myocardial Blood Flow

dc.contributor.authorMatthieu Dietz
dc.contributor.authorChristel H. Kamani
dc.contributor.authorColin Bousige
dc.contributor.authorVincent Dunet
dc.contributor.authorJudith Delage
dc.contributor.authorVladimir Rubimbura
dc.contributor.authorMarie Nicod Lalonde
dc.contributor.authorGiorgio Treglia
dc.contributor.authorNiklaus Schaefer
dc.contributor.authorWail Nammas
dc.contributor.authorAntti Saraste
dc.contributor.authorJuhani Knuuti
dc.contributor.authorNathan Mewton
dc.contributor.authorJohn O. Prior
dc.contributor.organizationfi=InFLAMES Lippulaiva|en=InFLAMES Flagship|
dc.contributor.organizationfi=PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=sisätautioppi|en=Internal Medicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.14646305228
dc.contributor.organization-code1.2.246.10.2458963.20.40502528769
dc.contributor.organization-code1.2.246.10.2458963.20.68445910604
dc.converis.publication-id393537920
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/393537920
dc.date.accessioned2025-08-28T02:52:58Z
dc.date.available2025-08-28T02:52:58Z
dc.description.abstract<p>Angiogenesis is an essential part of the cardiac repair process after myocardial infarction, but its spatiotemporal dynamics remain to be fully deciphered.<sup>68</sup>Ga-NODAGA-Arg-Gly-Asp (RGD) is a PET tracer targeting α<sub>v</sub>β<sub>3</sub> integrin expression, which is a marker of angiogenesis. <strong>Methods:</strong> In this prospective single-center trial, we aimed to monitor angiogenesis through myocardial integrin α<sub>v</sub>β<sub>3</sub> expression in 20 patients with ST-segment elevation myocardial infarction (STEMI). In addition, the correlations between the expression levels of myocardial α<sub>v</sub>β<sub>3</sub> integrin and the subsequent changes in <sup>82</sup>Rb PET/CT parameters, including rest and stress myocardial blood flow (MBF), myocardial flow reserve (MFR), and wall motion abnormalities, were assessed. The patients underwent <sup>68</sup>Ga-NODAGA-RGD PET/CT and rest and stress <sup>82</sup>Rb-PET/CT at 1 wk, 1 mo, and 3 mo after STEMI. To assess <sup>68</sup>Ga-NODAGA-RGD uptake, the summed rest <sup>82</sup>Rb and <sup>68</sup>Ga-NODAGA-RGD images were coregistered, and segmental SUVs were calculated (RGD SUV). <strong>Results:</strong> At 1 wk after STEMI, 19 participants (95%) presented increased <sup>68</sup>Ga-NODAGA-RGD uptake in the infarcted myocardium. Seventeen participants completed the full imaging series. The values of the RGD SUV in the infarcted myocardium were stable 1 mo after STEMI (1 wk vs. 1 mo, 1.47 g/mL [interquartile range (IQR), 1.37-1.64 g/mL] vs. 1.47 g/mL [IQR, 1.30-1.66 g/mL]; <em>P</em> = 0.9), followed by a significant partial decrease at 3 mo (1.32 g/mL [IQR, 1.12-1.71 g/mL]; <em>P</em> = 0.011 vs. 1 wk and 0.018 vs. 1 mo). In segment-based analysis, positive correlations were found between RGD SUV at 1 wk and the subsequent changes in stress MBF (Spearman ρ: <em>r</em> = 0.17, <em>P</em> = 0.0033) and MFR (Spearman ρ: <em>r</em> = 0.31, <em>P</em> < 0.0001) at 1 mo. A negative correlation was found between RGD SUV at 1 wk and the subsequent changes in wall motion abnormalities at 3 mo (Spearman ρ: <em>r</em> = <em>-</em>0.12, <em>P</em> = 0.035). <strong>Conclusion:</strong> The present study found that α<sub>v</sub>β<sub>3</sub> integrin expression is significantly increased in the infarcted myocardium 1 wk after STEMI. This expression remains stable after 1 mo and partially decreases after 3 mo. Initial α<sub>v</sub>β<sub>3</sub> integrin expression at 1 wk is significantly weakly correlated with subsequent improvements in stress MBF, MFR, and wall motion analysis.<br></p>
dc.format.pagerange1107
dc.format.pagerange1112
dc.identifier.eissn1535-5667
dc.identifier.jour-issn0161-5505
dc.identifier.olddbid209872
dc.identifier.oldhandle10024/192899
dc.identifier.urihttps://www.utupub.fi/handle/11111/49746
dc.identifier.urlhttps://jnm.snmjournals.org/content/early/2024/05/09/jnumed.124.267514
dc.identifier.urnURN:NBN:fi-fe2025082788474
dc.language.isoen
dc.okm.affiliatedauthorElnammas, Wail
dc.okm.affiliatedauthorSaraste, Antti
dc.okm.affiliatedauthorKnuuti, Juhani
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherSociety of Nuclear Medicine
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.2967/jnumed.124.267514
dc.relation.ispartofjournalJournal of Nuclear Medicine
dc.relation.issue7
dc.relation.volume65
dc.source.identifierhttps://www.utupub.fi/handle/10024/192899
dc.titleNatural History of Myocardial αvβ3 Integrin Expression After Acute Myocardial Infarction : Correlation with Changes in Myocardial Blood Flow
dc.year.issued2024

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
jnumed.124.267514.full.pdf
Size:
967.46 KB
Format:
Adobe Portable Document Format